Protein synthesis during sleep consolidates cortical plasticity in vivo

Curr Biol. 2012 Apr 24;22(8):676-82. doi: 10.1016/j.cub.2012.02.016. Epub 2012 Mar 1.

Abstract

Sleep consolidates experience-dependent brain plasticity, but the precise cellular mechanisms mediating this process are unknown [1]. De novo cortical protein synthesis is one possible mechanism. In support of this hypothesis, sleep is associated with increased brain protein synthesis [2, 3] and transcription of messenger RNAs (mRNAs) involved in protein synthesis regulation [4, 5]. Protein synthesis in turn is critical for memory consolidation and persistent forms of plasticity in vitro and in vivo [6, 7]. However, it is unknown whether cortical protein synthesis in sleep serves similar functions. We investigated the role of protein synthesis in the sleep-dependent consolidation of a classic form of cortical plasticity in vivo (ocular dominance plasticity, ODP; [8, 9]) in the cat visual cortex. We show that intracortical inhibition of mammalian target of rapamycin (mTOR)-dependent protein synthesis during sleep abolishes consolidation but has no effect on plasticity induced during wakefulness. Sleep also promotes phosphorylation of protein synthesis regulators (i.e., 4E-BP1 and eEF2) and the translation (but not transcription) of key plasticity related mRNAs (ARC and BDNF). These findings show that sleep promotes cortical mRNA translation. Interruption of this process has functional consequences, because it abolishes the consolidation of experience in the cortex.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor / genetics
  • Cats
  • Dominance, Ocular
  • Mediator Complex / genetics
  • Neuronal Plasticity / physiology*
  • Phosphoproteins / metabolism
  • Phosphorylation
  • Protein Biosynthesis / physiology*
  • Sleep / physiology*
  • TOR Serine-Threonine Kinases / metabolism
  • Transcription, Genetic
  • Wakefulness / physiology

Substances

  • Brain-Derived Neurotrophic Factor
  • DRIP, VDR interacting protein complex
  • Mediator Complex
  • Phosphoproteins
  • TOR Serine-Threonine Kinases